Guidelines on Preventing Cardiovascular Disease in Clinical Practice

Overview

Journal BMJ

Specialty General Medicine

Date 2000 Mar 11

PMID 10710556

Citations 36

Authors

R Jackson

Affiliations

Soon will be listed here.

Citing Articles

The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.

Xu Y, Derakhshan A, Hysaj O, Wildisen L, Ittermann T, Pingitore A Lancet Diabetes Endocrinol. 2023; 11(10):743-754.

PMID: 37696273 PMC: 10866328. DOI: 10.1016/S2213-8587(23)00227-9.

Multivariate Sequential Analytics for Cardiovascular Disease Event Prediction.

Hsu W, Warren J, Riddle P Methods Inf Med. 2022; 61(S 02):e149-e171.

PMID: 36564011 PMC: 9788915. DOI: 10.1055/s-0042-1758687.

Actionable absolute risk prediction of atherosclerotic cardiovascular disease based on the UK Biobank.

Kesar A, Baluch A, Barber O, Hoffmann H, Jovanovic M, Renz D PLoS One. 2022; 17(2):e0263940.

PMID: 35148360 PMC: 8836294. DOI: 10.1371/journal.pone.0263940.

Ten-year risk of fatal cardiovascular disease and its association with metabolic risk factors among waste pickers in South Africa.

Made F, Nonterah E, Tlotleng N, Ntlebi V, Naicker N BMC Cardiovasc Disord. 2021; 21(1):336.

PMID: 34246223 PMC: 8272349. DOI: 10.1186/s12872-021-02150-y.

Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large population-based cohort study and external validation.

Ajnakina O, Agbedjro D, McCammon R, Faul J, Murray R, Stahl D BMC Med Res Methodol. 2021; 21(1):8.

PMID: 33407175 PMC: 7789636. DOI: 10.1186/s12874-020-01204-7.

References

Law M, Wald N, Thompson S . By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ. 1994; 308(6925):367-72. PMC: 2539460. DOI: 10.1136/bmj.308.6925.367. View

Montgomery A, Fahey T, Peters T, MacIntosh C, Sharp D . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ. 2000; 320(7236):686-90. PMC: 27312. DOI: 10.1136/bmj.320.7236.686. View

Baker S, Priest P, Jackson R . Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ. 2000; 320(7236):680-5. PMC: 27311. DOI: 10.1136/bmj.320.7236.680. View

Ramachandran S, French J, Vanderpump M, Croft P, Neary R . Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?. BMJ. 2000; 320(7236):677-9. PMC: 27309. DOI: 10.1136/bmj.320.7236.677. View

Ramachandran S, French J, Vanderpump M, Croft P, Neary R . Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ. 2000; 320(7236):676-7. PMC: 27308. DOI: 10.1136/bmj.320.7236.676. View

Wallis E, Ramsay L, Ul Haq I, Ghahramani P, Jackson P, Rowland-Yeo K . Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ. 2000; 320(7236):671-6. PMC: 27307. DOI: 10.1136/bmj.320.7236.671. View

Larosa J, He J, Vupputuri S . Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999; 282(24):2340-6. DOI: 10.1001/jama.282.24.2340. View

Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J . Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999; 13(9):569-92. DOI: 10.1038/sj.jhh.1000917. View

Robson J, Boomla K, Hart B, Feder G . Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. BMJ. 2000; 320(7236):702-4. PMC: 1117714. DOI: 10.1136/bmj.320.7236.702. View

10.

. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. BMJ. 2000; 320(7236):705-8. PMC: 1117715. DOI: 10.1136/bmj.320.7236.705. View

11.

Jackson R . Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000; 320(7236):709-10. PMC: 1117717. DOI: 10.1136/bmj.320.7236.709. View

12.

Martin M, Hulley S, Browner W, Kuller L, Wentworth D . Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986; 2(8513):933-6. DOI: 10.1016/s0140-6736(86)90597-0. View

13.

. 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens. 1989; 7(8):689-93. DOI: 10.1097/00004872-198908000-00014. View

14.

Collins R, Peto R, Macmahon S, Hebert P, Fiebach N, Eberlein K . Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990; 335(8693):827-38. DOI: 10.1016/0140-6736(90)90944-z. View

15.

Anderson K, Odell P, Wilson P, Kannel W . Cardiovascular disease risk profiles. Am Heart J. 1991; 121(1 Pt 2):293-8. DOI: 10.1016/0002-8703(91)90861-b. View

16.

Rose G . Environmental health: problems and prospects. J R Coll Physicians Lond. 1991; 25(1):48-52. PMC: 5377100. View

17.

Mann J, Crooke M, Fear H, HAY D, Jackson R, NEUTZE J . Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. N Z Med J. 1993; 106(953):133-41. View

18.

Jackson R, Barham P, Bills J, Birch T, McLennan L, Macmahon S . Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993; 307(6896):107-10. PMC: 1693500. DOI: 10.1136/bmj.307.6896.107. View

19.

Isles C, Ritchie L, Murchie P, Norrie J . Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods. BMJ. 2000; 320(7236):690-1. PMC: 27313. DOI: 10.1136/bmj.320.7236.690. View

20.

Mulrow C, CORNELL J, Herrera C, Kadri A, Farnett L, Aguilar C . Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA. 1994; 272(24):1932-8. View